Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease
Wang, Z., Rahkola, J., Redzic, J.S., Chi, Y.C., Tran, N., Holyoak, T., Zheng, H., Janoff, E., Eisenmesser, E.Z.(2020) Nat Commun 11: 6063
- PubMed: 33247098 
- DOI: https://doi.org/10.1038/s41467-020-19887-3
- Primary Citation of Related Structures:  
6XJA, 6XJB, 7JGJ - PubMed Abstract: 
Opportunistic pathogens such as Streptococcus pneumoniae secrete a giant metalloprotease virulence factor responsible for cleaving host IgA1, yet the molecular mechanism has remained unknown since their discovery nearly 30 years ago despite the potential for developing vaccines that target these enzymes to block infection. Here we show through a series of cryo-electron microscopy single particle reconstructions how the Streptococcus pneumoniae IgA1 protease facilitates IgA1 substrate recognition and how this can be inhibited. Specifically, the Streptococcus pneumoniae IgA1 protease subscribes to an active-site-gated mechanism where a domain undergoes a 10.0 Å movement to facilitate cleavage. Monoclonal antibody binding inhibits this conformational change, providing a direct means to block infection at the host interface. These structural studies explain decades of biological and biochemical studies and provides a general strategy to block Streptococcus pneumoniae IgA1 protease activity to potentially prevent infection.
Organizational Affiliation: 
Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO, 80045, USA.